TSXV - Delayed Quote CAD

Hydreight Technologies Inc. (NURS.V)

Compare
2.3000
+0.0100
+(0.44%)
At close: January 14 at 3:59:59 PM EST
Loading Chart for NURS.V
DELL
  • Previous Close 2.2900
  • Open 2.3300
  • Bid 2.3000 x --
  • Ask 2.3700 x --
  • Day's Range 2.2000 - 2.3700
  • 52 Week Range 0.2000 - 2.4900
  • Volume 56,481
  • Avg. Volume 108,506
  • Market Cap (intraday) 92.683M
  • Beta (5Y Monthly) -0.12
  • PE Ratio (TTM) --
  • EPS (TTM) -0.0300
  • Earnings Date Nov 26, 2024
  • Forward Dividend & Yield --
  • Ex-Dividend Date --
  • 1y Target Est --

Hydreight Technologies Inc. provides mobile health and wellness services primarily in the United States. Its Hydreight App offers consulting and advising in setting up their health and wellness services, including assistance with finding experienced advisors in the areas of medical and privacy law; medical liability insurance; pharmaceutical IV programs vetted by duly licensed pharmacists; procedural guides to various services, such as Botox, fillers, etc.; and hiring, on-boarding, training, marketing, branding, payroll, and other accounting services. The company operates health related application, as well as involved in pharmaceutical sales. Hydreight Technologies Inc. is headquartered in Las Vegas, Nevada.

hydreight.com

--

Full Time Employees

December 31

Fiscal Year Ends

Recent News: NURS.V

View More

Performance Overview: NURS.V

Trailing total returns as of 1/14/2025, which may include dividends or other distributions. Benchmark is

.

YTD Return

NURS.V
35.29%
S&P/TSX Composite index
0.13%

1-Year Return

NURS.V
557.14%
S&P/TSX Composite index
17.14%

3-Year Return

NURS.V
253.85%
S&P/TSX Composite index
15.48%

5-Year Return

NURS.V
253.85%
S&P/TSX Composite index
42.18%

Compare To: NURS.V

Select to analyze similar companies using key performance metrics; select up to 4 stocks.

Statistics: NURS.V

View More

Valuation Measures

As of 1/14/2025
  • Market Cap

    92.68M

  • Enterprise Value

    90.27M

  • Trailing P/E

    --

  • Forward P/E

    --

  • PEG Ratio (5yr expected)

    --

  • Price/Sales (ttm)

    5.78

  • Price/Book (mrq)

    --

  • Enterprise Value/Revenue

    5.87

  • Enterprise Value/EBITDA

    --

Financial Highlights

Profitability and Income Statement

  • Profit Margin

    -12.04%

  • Return on Assets (ttm)

    -33.50%

  • Return on Equity (ttm)

    --

  • Revenue (ttm)

    13.94M

  • Net Income Avi to Common (ttm)

    -1.68M

  • Diluted EPS (ttm)

    -0.0300

Balance Sheet and Cash Flow

  • Total Cash (mrq)

    1.4M

  • Total Debt/Equity (mrq)

    --

  • Levered Free Cash Flow (ttm)

    398.1k

Research Analysis: NURS.V

View More

People Also Watch